- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT05047172
Comparação de terapias anticoagulantes e antiplaquetárias para aterostenose vascular intracraniana (CAPTIVA)
Comparação de terapias anticoagulantes e antiplaquetárias para aterostenose vascular intracraniana (CAPTIVA)
The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracerebral hemorrhage, or vascular death.
Visão geral do estudo
Status
Condições
Descrição detalhada
The proposed study is relevant to public health because narrowing of brain arteries is one of the most common causes of stroke worldwide. Compelling evidence suggests novel antithrombotic medications could reduce the rate of stroke in patients with narrowed brain arteries. The proposed study will directly compare novel antithrombotic medications to standard care antiplatelet medications for preventing stroke and death from vascular causes in patients with narrowed brain arteries.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Fase 3
Contactos e Locais
Locais de estudo
-
-
Alabama
-
Birmingham, Alabama, Estados Unidos, 35233
- University of Alabama Hospital
-
Mobile, Alabama, Estados Unidos, 36604
- University of South Alabama University Hospital
-
-
Arizona
-
Phoenix, Arizona, Estados Unidos, 85013
- St. Joseph's Hospital and Medical Center
-
-
California
-
Carmichael, California, Estados Unidos, 95608
- Mercy San Juan Medical Center
-
Chula Vista, California, Estados Unidos, 91910
- The Neuron Clinic - Chula Vista
-
Fontana, California, Estados Unidos, 92335
- Kaiser Permanente Fontana Medical Center
-
Long Beach, California, Estados Unidos, 90806
- Long Beach Memorial Medical Center
-
Los Alamitos, California, Estados Unidos, 90720
- Los Alamitos Medical Center
-
Los Angeles, California, Estados Unidos, 90027
- Kaiser Permanente Los Angeles Medical Center
-
Los Angeles, California, Estados Unidos, 90095
- Ronald Reagan UCLA Medical Center, Los Angeles, CA
-
Orange, California, Estados Unidos, 92868
- UC Irvine Medical Center
-
Sacramento, California, Estados Unidos, 95817
- UC Davis Medical Center
-
Salinas, California, Estados Unidos, 93901
- Salinas Valley Memorial Hospital
-
San Diego, California, Estados Unidos, 92103
- UCSD Medical Center - Hillcrest Hospital
-
Torrance, California, Estados Unidos, 90503
- Providence Little Company of Mary Medical Center Torrance
-
-
Colorado
-
Aurora, Colorado, Estados Unidos, 80045
- University of Colorado Hospital
-
Grand Junction, Colorado, Estados Unidos, 81501
- St. Mary's Medical Center
-
-
Connecticut
-
Hartford, Connecticut, Estados Unidos, 06102
- Hartford Hospital
-
New Haven, Connecticut, Estados Unidos, 06520
- Yale New Haven Hospital
-
-
District of Columbia
-
Washington D.C., District of Columbia, Estados Unidos, 20010
- MedStar Washington Hospital Center
-
-
Florida
-
Clearwater, Florida, Estados Unidos, 33756
- Morton Plant Hospital
-
Gainesville, Florida, Estados Unidos, 32608
- UF Health Shands Hospital
-
Jacksonville, Florida, Estados Unidos, 32224
- Mayo Clinic
-
Jacksonville, Florida, Estados Unidos, 32207
- Baptist Medical Center Jacksonville
-
Miami, Florida, Estados Unidos, 33136
- Jackson Memorial Hospital
-
Port Saint Lucie, Florida, Estados Unidos, 34987
- Cleveland Clinic Tradition Hospital
-
Tampa, Florida, Estados Unidos, 33606
- Tampa General Hospital
-
-
Georgia
-
Atlanta, Georgia, Estados Unidos, 30303
- Grady Memorial Hospital
-
Atlanta, Georgia, Estados Unidos, 30303
- Emory University Hospital
-
Augusta, Georgia, Estados Unidos, 30912
- Augusta University Medical Center
-
-
Illinois
-
Carbondale, Illinois, Estados Unidos, 62901
- Memorial Hospital of Carbondale
-
Chicago, Illinois, Estados Unidos, 60612
- Rush University Medical Center
-
Chicago, Illinois, Estados Unidos, 60612
- University of Illinois Hospital
-
Chicago, Illinois, Estados Unidos, 60637
- University of Chicago Medical Center
-
Evanston, Illinois, Estados Unidos, 60201
- Evanston Hospital
-
Oak Lawn, Illinois, Estados Unidos, 60453
- Advocate Christ Medical Center
-
Rockford, Illinois, Estados Unidos, 61114
- Javon Bea Hospital - Riverside
-
-
Kansas
-
Kansas City, Kansas, Estados Unidos, 66160
- University of Kansas Hospital
-
-
Kentucky
-
Lexington, Kentucky, Estados Unidos, 40503
- Baptist Health Lexington
-
Lexington, Kentucky, Estados Unidos, 40536
- University of Kentucky Hospital
-
-
Louisiana
-
New Orleans, Louisiana, Estados Unidos, 70121
- Ochsner Medical Center - Main Campus
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21201
- University of Maryland Medical Center
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02215
- Beth Israel Deaconess Medical Center
-
Boston, Massachusetts, Estados Unidos, 02115
- Brigham and Women's Hospital
-
Boston, Massachusetts, Estados Unidos, 02114
- Massachusetts General Hospital
-
Boston, Massachusetts, Estados Unidos, 02118
- Boston Medical Center
-
Worcester, Massachusetts, Estados Unidos, 01655
- UMass Memorial Medical Center
-
-
Michigan
-
Detroit, Michigan, Estados Unidos, 48202
- Henry Ford Hospital
-
Flint, Michigan, Estados Unidos, 48532
- McLaren Flint
-
Mount Clemens, Michigan, Estados Unidos, 48043
- McLaren Macomb
-
Wyoming, Michigan, Estados Unidos, 49519
- Metro Health Hospital
-
-
Minnesota
-
Edina, Minnesota, Estados Unidos, 55414
- M Health Fairview Southdale Hospital
-
Minneapolis, Minnesota, Estados Unidos, 55407
- Abbott Northwestern Hospital
-
Minneapolis, Minnesota, Estados Unidos, 55415
- M Health Fairview University of Minnesota Medical Center
-
-
Mississippi
-
Jackson, Mississippi, Estados Unidos, 39216
- University of Mississippi Medical Center
-
-
Missouri
-
Columbia, Missouri, Estados Unidos, 65212
- University of Missouri Health Care
-
St Louis, Missouri, Estados Unidos, 62269
- Barnes Jewish Hospital
-
-
Nebraska
-
Omaha, Nebraska, Estados Unidos, 68198
- University of Nebraska Medical Center
-
-
New Jersey
-
Camden, New Jersey, Estados Unidos, 08103
- Cooper University Hospital
-
Neptune City, New Jersey, Estados Unidos, 07753
- Jersey Shore University Medical Center
-
Ridgewood, New Jersey, Estados Unidos, 07450
- Valley Hospital
-
-
New Mexico
-
Albuquerque, New Mexico, Estados Unidos, 87106
- University of New Mexico Hospital
-
-
New York
-
Brooklyn, New York, Estados Unidos, 11203
- SUNY Downstate Medical Center
-
Brooklyn, New York, Estados Unidos, 11203
- Kings County Hospital Center
-
Brooklyn, New York, Estados Unidos, 11220
- NYU Langone Hospital - Brooklyn
-
Buffalo, New York, Estados Unidos, 14202
- Buffalo General Medical Center
-
Lake Success, New York, Estados Unidos, 11042
- North Shore University Hospital
-
New York, New York, Estados Unidos, 10029
- The Mount Sinai Hospital
-
New York, New York, Estados Unidos, 10021
- NYP Weill Cornell Medical Center
-
New York, New York, Estados Unidos, 10032
- NYP Columbia University Medical Center
-
Rochester, New York, Estados Unidos, 14642
- Strong Memorial Hospital
-
The Bronx, New York, Estados Unidos, 10467
- Montefiore Medical Center
-
-
North Carolina
-
Charlotte, North Carolina, Estados Unidos, 28207
- Carolinas Medical Center
-
Durham, North Carolina, Estados Unidos, 27710
- Duke University Hospital
-
Greensboro, North Carolina, Estados Unidos, 27405
- Moses H. Cone Memorial Hospital
-
Greenville, North Carolina, Estados Unidos, 27834
- ECU Health Medical Center
-
Winston-Salem, North Carolina, Estados Unidos, 27157
- Wake Forest Baptist Medical Center
-
-
Ohio
-
Akron, Ohio, Estados Unidos, 44307
- Cleveland Clinic Akron General
-
Cincinnati, Ohio, Estados Unidos, 45267
- University of Cincinnati Medical Center
-
Cincinnati, Ohio, Estados Unidos, 45220
- Good Samaritan Hospital
-
Cleveland, Ohio, Estados Unidos, 44195
- Cleveland Clinic
-
Cleveland, Ohio, Estados Unidos, 44106
- UH Cleveland Medical Center
-
Columbus, Ohio, Estados Unidos, 43210
- OSU Wexner Medical Center
-
Toledo, Ohio, Estados Unidos, 43608
- Mercy St. Vincent Medical Center
-
Toledo, Ohio, Estados Unidos, 43606
- Toledo Hospital
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Estados Unidos, 73104
- OU Medical Center
-
-
Oregon
-
Portland, Oregon, Estados Unidos, 97225
- Providence St. Vincent Medical Center
-
Portland, Oregon, Estados Unidos, 97239
- Oregon Health & Science University Hospital
-
-
Pennsylvania
-
Abington, Pennsylvania, Estados Unidos, 19001
- Jefferson Abington Hospital
-
Altoona, Pennsylvania, Estados Unidos, 16601
- UPMC Altoona
-
Erie, Pennsylvania, Estados Unidos, 16550
- UPMC Hamot
-
Philadelphia, Pennsylvania, Estados Unidos, 19104
- Hospital of the University of Pennsylvania
-
Philadelphia, Pennsylvania, Estados Unidos, 19107
- Thomas Jefferson University Hospital
-
Philadelphia, Pennsylvania, Estados Unidos, 19140
- Temple University Hospital, Philadelphia
-
Pittsburgh, Pennsylvania, Estados Unidos, 15213
- UPMC Presbyterian Hospital
-
-
Rhode Island
-
Providence, Rhode Island, Estados Unidos, 02903
- Rhode Island Hospital
-
-
South Carolina
-
Charleston, South Carolina, Estados Unidos, 29425
- Medical University of South Carolina University Hospital
-
Columbia, South Carolina, Estados Unidos, 29203
- Prisma Health Richland Hospital
-
Greenville, South Carolina, Estados Unidos, 29605
- Prisma Health Greenville Memorial Hospital
-
-
Tennessee
-
Memphis, Tennessee, Estados Unidos, 38104
- Methodist University Hospital
-
-
Texas
-
Galveston, Texas, Estados Unidos, 77555
- University of Texas Medical Branch
-
Houston, Texas, Estados Unidos, 77030
- Houston Methodist Hospital
-
Houston, Texas, Estados Unidos, 77030
- Memorial Hermann Texas Medical Center
-
Lubbock, Texas, Estados Unidos, 79410
- Covenant Medical Center
-
Plano, Texas, Estados Unidos, 75075
- Medical City Plano
-
San Antonio, Texas, Estados Unidos, 78229
- University of Texas Health Science Center San Antonio
-
Tyler, Texas, Estados Unidos, 75708
- UT Health Tyler
-
-
Vermont
-
Burlington, Vermont, Estados Unidos, 05401
- The University of Vermont Medical Center
-
-
Virginia
-
Charlottesville, Virginia, Estados Unidos, 22903
- UVA Medical Center
-
Falls Church, Virginia, Estados Unidos, 22042
- Inova Fairfax Hospital
-
Roanoke, Virginia, Estados Unidos, 24011
- Carilion Roanoke Memorial Hospital
-
-
Washington
-
Seattle, Washington, Estados Unidos, 98104
- Harborview Medical Center
-
Seattle, Washington, Estados Unidos, 98122
- Swedish Medical Center - Cherry Hill Campus
-
-
Wisconsin
-
Madison, Wisconsin, Estados Unidos, 53792
- University of Wisconsin University Hospital
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
-
Acute focal symptoms or signs of any duration associated with imaging, pathological, or other objective evidence of arterial infarction OR clinical evidence of cerebral, spinal cord, or retinal focal arterial ischemic injury based on symptoms persisting greater than or equal to 24 hours that occurred within 30 days prior to randomization
-
Index stroke is attributed to 70-99% stenosis (or flow gap on MRA) of a major intracranial artery (carotid artery, middle cerebral artery (M1 or M2), vertebral artery (V4), basilar artery, posterior cerebral artery (P1), or anterior cerebral artery (A1)) documented by CTA, MRA, or catheter angiography
-
Modified Rankin Scale score of ≤ 4, at time of consent
-
Ability to swallow pills
-
At least 30 years of age, inclusive, at time of consent
-
Subjects 30-49 years of age are required to meet at least ONE of the following additional criteria below to qualify for the study:
- diabetes treated with insulin for at least 15 years
- at least 2 of the following atherosclerotic risk factors: hypertension (BP > 140/90 or on antihypertensive therapy); dyslipidemia (LDL > 130 mg /dl or HDL < 40 mg/dl or fasting triglycerides > 150 mg/dl or on lipid lowering therapy); smoking; non-insulin dependent diabetes or insulin dependent diabetes of less than 15 years duration; any of the following vascular events occurring in a parent or sibling who was < 55 years of age for men or < 65 years of age for women at the time of the event: myocardial infarction, coronary artery bypass, coronary angioplasty or stenting, stroke, carotid endarterectomy or stenting, peripheral vascular surgery for atherosclerotic disease
- personal history of any of the following: myocardial infarction, coronary artery bypass, coronary angioplasty or stenting, carotid endarterectomy or stenting, or peripheral vascular surgery for atherosclerotic disease
- any stenosis of an extracranial carotid or vertebral artery, another intracranial artery, subclavian artery, coronary artery, iliac or femoral artery, other lower or upper extremity artery, mesenteric artery, or renal artery that was documented by non-invasive vascular imaging or catheter angiography and is considered atherosclerotic
- aortic arch atheroma documented by non-invasive vascular imaging or catheter angiography
- any aortic aneurysm documented by non-invasive vascular imaging or catheter angiography that is considered atherosclerotic
-
Negative pregnancy test in a female who has had any menses in the last 18 months and has not had surgery that would make her unable to become pregnant
-
Subject is willing and able to return for all follow-up evaluations required by the protocol
-
Subject is available by phone
-
Subject understands the purpose and requirements of the study and can make him/herself understood
-
Subject has provided informed consent (use of a LAR is not permitted)
Exclusion Criteria:
- Previous treatment of qualifying intracranial artery with a stent, angioplasty, or other mechanical device, including mechanical thrombectomy for the qualifying stroke, or plan to perform one of these procedures
- Plan to perform concomitant endarterectomy, angioplasty or stenting of an extracranial vessel tandem to the symptomatic intracranial stenosis
- Intracranial tumor (except meningioma) or any intracranial vascular malformation
- Thrombolytic therapy within 24 hours prior to randomization
- Progressive neurological signs within 24 hours prior to randomization
- History of spontaneous non-traumatic intracranial hemorrhage (parenchymal, subarachnoid, subdural, epidural)
- Intracranial arterial stenosis due to: arterial dissection; MoyaMoya disease; any known vasculitic disease; herpes zoster, varicella zoster or other viral vasculopathy; neurosyphilis; any other intracranial infection; any intracranial stenosis associated with CSF pleocytosis; radiation induced vasculopathy; fibromuscular dysplasia; sickle cell disease; neurofibromatosis; benign angiopathy of central nervous system; postpartum angiopathy; suspected vasospastic process; reversible cerebral vasoconstriction syndrome (RCVS); suspected recanalized embolus
- Presence of any of the following unequivocal cardiac sources of embolism: chronic or paroxysmal atrial fibrillation, mitral stenosis, mechanical valve, endocarditis, intracardiac clot or vegetation, myocardial infarction within three months, left atrial spontaneous echo contrast
- Known allergy or contraindication to aspirin, rivaroxaban, clopidogrel, or ticagrelor
- Uncontrolled severe hypertension (systolic pressure > 180 mm Hg or diastolic pressure > 115 mm Hg), active peptic ulcer disease, major systemic hemorrhage within 30 days prior to randomization, active bleed or bleeding diathesis, platelets < 100,000, hematocrit < 30, INR > 1.5, clotting factor abnormality that increases the risk of bleeding, current alcohol or substance abuse, severe liver impairment (AST or ALT > 3 x normal, cirrhosis), or CrCl < 15 mL/min or on dialysis
- Major surgery (including stenting of any vessel; open femoral, aortic, or carotid surgery; or cardiac surgery) within previous 30 days prior to randomization or planned in the next 90 days after randomization
- Any condition other than intracranial arterial stenosis that requires the subject to take any antithrombotic medication other than aspirin (NOTE: exceptions allowed for subcutaneous heparin or enoxaparin for deep vein thrombosis (DVT) prophylaxis)
- Dementia or psychiatric problem that prevents the subject from following an outpatient program reliably
- Co-morbid conditions that may limit survival to less than 12 months
- Pregnancy or of childbearing potential and unwilling to use contraception for the duration of this study, or currently breastfeeding
- Current or anticipated concomitant oral or intravenous therapy with strong CYP3A4 inhibitors or CYP3A4 substrates that cannot be stopped for the course of this study
- Enrollment in another study that would conflict with the current study
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Quadruplicar
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Experimental Arm: Ticagrelor and Aspirin
Ticagrelor (180mg loading dose, then 90mg twice daily) and aspirin (81mg daily) |
ticagrelor (180 mg loading dose, then 90mg twice daily) and aspirin (81mg daily)
Outros nomes:
Risk factors for stroke (LDL, blood pressure, non-HDL cholesterol, diabetes, smoking, weight, and physical activity) will be monitored and managed. |
|
Comparador Ativo: Standard of Care Arm: Clopidogrel and Aspirin
Clopidogrel (600mg loading dose, then 75mg once daily) and aspirin (81mg daily) |
Risk factors for stroke (LDL, blood pressure, non-HDL cholesterol, diabetes, smoking, weight, and physical activity) will be monitored and managed. clopidogrel (600mg loading dose, then 75mg daily) and aspirin (81mg daily)
Outros nomes:
|
|
Experimental: Experimental Arm: Rivaroxaban and Aspirin
Rivaroxaban (2.5mg twice daily) and aspirin (81mg daily) |
Risk factors for stroke (LDL, blood pressure, non-HDL cholesterol, diabetes, smoking, weight, and physical activity) will be monitored and managed. low dose rivaroxaban (2.5mg twice daily) and aspirin (81mg daily)
Outros nomes:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Number of participants with parenchymal ICH or non-ICH major hemorrhage
Prazo: Up to 12 months
|
Non-ICH major hemorrhage is derived from the International Society on Thrombosis and Haemostasis (ISTH) criteria consisting of any of the following:
|
Up to 12 months
|
|
Number of participants with ischemic stroke, intracerebral hemorrhage or vascular death
Prazo: Up to 12 months
|
The definition of ischemic stroke is the American Heart Association definition that includes acute focal signs or symptoms of cerebral, spinal cord, or retinal involvement of any duration associated with imaging, pathological, or other objective evidence of arterial infarction OR clinical evidence of cerebral, spinal cord, or retinal focal arterial ischemic injury based on symptoms persisting greater than or equal to 24 hours. |
Up to 12 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Brian L. Hoh, MD, MBA, University of Florida
- Investigador principal: Marc I. Chimowitz, MBChB, Medical University of South Carolina
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
- Distúrbios Cerebrovasculares
- Doenças Cerebrais
- Doenças do Sistema Nervoso Central
- Doenças do Sistema Nervoso
- Doenças Vasculares
- Doenças cardiovasculares
- Arteriosclerose
- Doenças Arteriais Oclusivas
- Doenças Arteriais Intracranianas
- Derrame
- Arteriosclerose Intracraniana
- Compostos de enxofre
- Produtos químicos orgânicos
- Piridinas
- Compostos heterocíclicos, 1 anel
- Compostos heterocíclicos
- Compostos heterocíclicos, 2 anel
- Compostos heterocíclicos, anel fundido
- Ácidos nucleicos, nucleotídeos e nucleosídeos
- Hidrocarbonetos
- Hidrocarbonetos, cíclicos
- Hidrocarbonetos, aromáticos
- Purinas
- Fenóis
- Derivados de benzeno
- Nucleosídeos
- Ribonucleosídeos
- Morfolinas
- Oxazinas
- Tiofenos
- Salicilatos
- Hidroxibenzoatos
- Adenosina
- Nucleosídeos de purina
- Ticlopidina
- Tienopiridinas
- Ticagrelor
- Clopidogrel
- Rivaroxabana
- Aspirina
Outros números de identificação do estudo
- CED000000522
- AWD10099 (Outro identificador: UFIRST)
- U01NS117450 (Concessão/Contrato do NIH dos EUA)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
produto fabricado e exportado dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .